MannKind Corp (NASDAQ:MNKD)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer.

Results 1 - 20 of 165 : 1 2 3 4 5 6 7 8 9 Next »

Recs

0
Member Avatar jakemeactual (< 20) Submitted: 8/21/2014 10:24:27 AM : Outperform Start Price: $7.11 MNKD Score: +2.88

bought 270 shares

Recs

0
Member Avatar AMax101 (34.41) Submitted: 7/24/2014 11:33:13 AM : Underperform Start Price: $9.46 MNKD Score: +22.94

Afrezza sales will be a disappointment. Labeling issues will restrict doctors from actually prescribing the drug. Predicting another Exubera bust.

Recs

0
Member Avatar RCSingh (< 20) Submitted: 7/23/2014 11:56:38 PM : Outperform Start Price: $9.50 MNKD Score: -23.37

Mannkind is sitting on an up and coming pop in the near-term future. Yes the analysts who say that the upside of increased earnings (slash the very existence of earnings) is already factored into the price of the stock are correct. But the old adage of "buy the rumor, sell the news" still works as well today as it used to. Once the rumors about which distributor(s) they're talking to come to the surface, this one is a great candidate for deep ITM leaps...takes the worrying out of waiting for those rumors to come to light.

Recs

0
Member Avatar longverylong (< 20) Submitted: 7/11/2014 7:41:34 PM : Outperform Start Price: $10.11 MNKD Score: -28.67

ADCOM - +ve
Approval - YESSSS
BUyout - Maybe
Partnership - Maybe
Before July 18... Hope so :)

Recs

0
Member Avatar ArdyAr (86.00) Submitted: 6/30/2014 3:12:18 PM : Outperform Start Price: $11.03 MNKD Score: -35.69

Saves the diabetic from injections.

Recs

1
Member Avatar Topdoginvesting1 (< 20) Submitted: 6/30/2014 10:34:19 AM : Outperform Start Price: $11.00 MNKD Score: -35.44

Partnership or Buyout, no doubter..

Recs

1
Member Avatar Investinguppy (< 20) Submitted: 6/17/2014 11:01:54 PM : Outperform Start Price: $10.59 MNKD Score: -33.42

Inhalable insulin might become a game changer. The technosphere technology might also be useful for a number of different drugs, and the CEO Al Mann has experience bringing medical devices to market (previously insulin pumps).

My largest holding.

Recs

0
Member Avatar FNN31 (27.89) Submitted: 6/12/2014 3:44:14 AM : Underperform Start Price: $10.38 MNKD Score: +32.11

Even if they get FDA approval, there is commercialization hurdle, and then the market pentration hurdle. Efficacy will be first concern and then safety.

Recs

0
Member Avatar jastep1 (< 20) Submitted: 6/3/2014 7:57:43 PM : Outperform Start Price: $9.71 MNKD Score: -28.38

This company has jumped through all the hoops thrown in front if it by the FDA. Inhaled insulin represents a new treatment which allows the administration of insulin without a needle, and works well according to several testimonials so far. Given the increasing number of diabetics it will likely soar.

Recs

0
Member Avatar cofcgrad (< 20) Submitted: 5/31/2014 12:39:52 AM : Outperform Start Price: $9.05 MNKD Score: -22.59

Game changing product in an ever increasing user base.

Recs

0
Member Avatar byonts (< 20) Submitted: 4/23/2014 12:32:05 PM : Outperform Start Price: $6.39 MNKD Score: +8.41

Developed an inhalant insulin for both type 1 and type 2 diabetis. It is not yet approved, but this is major break in diabetis treatment.

Recs

0
Member Avatar DrGarnicus (30.77) Submitted: 4/10/2014 3:37:47 PM : Outperform Start Price: $6.90 MNKD Score: -2.47

July 15th

Recs

0
Member Avatar Piggybank99 (75.28) Submitted: 4/4/2014 6:48:14 PM : Outperform Start Price: $6.12 MNKD Score: +12.46

This company recently got its inhalable insulin approved by the FDA, and once it gets on the market, prices will go through the roof.

Recs

0
Member Avatar kickbishopbrenna (42.16) Submitted: 4/4/2014 10:42:57 AM : Outperform Start Price: $6.87 MNKD Score: +1.16

no insulin injections..wow, its a "pot-shot" but with FDA approval discussions due to start, its worth a punt, especially as the select committee have recommended it.

Recs

0
Member Avatar seti03 (< 20) Submitted: 3/28/2014 4:22:43 PM : Outperform Start Price: $4.44 MNKD Score: +58.46


hmmm, works quicker and no more sticking yourself like a pin cushion. What's not to approve???

Recs

2
Member Avatar usubanas (99.48) Submitted: 3/28/2014 1:55:16 PM : Underperform Start Price: $5.02 MNKD Score: -38.70

predict FDA panel will vote negatively next week.

Recs

1
Member Avatar MOEHESTON (< 20) Submitted: 3/22/2014 9:41:19 AM : Outperform Start Price: $5.90 MNKD Score: +17.48

Unless all are not being told something. All elements have been answered. The ADCOM article (yet to surface) will probably not paint a favorable picture creating one more dip. Then FDA response (April 15th).

Recs

2
Member Avatar palm91 (21.19) Submitted: 3/3/2014 2:42:13 PM : Outperform Start Price: $6.08 MNKD Score: +12.81

best bet in biomeds, look for 25billion MC

Recs

0
Member Avatar jdowning22 (< 20) Submitted: 1/18/2014 8:06:56 PM : Outperform Start Price: $5.56 MNKD Score: +23.04

New drug coming soon... Hopefully

Recs

0
Member Avatar dswallen (49.99) Submitted: 1/15/2014 5:44:35 PM : Outperform Start Price: $6.00 MNKD Score: +13.92

Thinking the drug gets approved and we get a big pop. After that, time to sell sell sell.

Featured Broker Partners


Advertisement